CRC Research Update — October 27, 2026
Today's colorectal cancer research highlights
Curated CRC research, accessible, accurate, actionable
The CRC Digest
Tuesday, October 27, 2026
IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.
CRC Research Update
-
TRIAL DATA
Early-onset colorectal cancer in Korea shows lower mortality than late-onset diseaseA nationwide study of 20,941 patients found that early-onset CRC (diagnosed before age 50) was associated with lower overall mortality, cancer-specific mortality, and non-cancer mortality compared to late-onset disease, with the mortality difference greatest in localized disease and stronger in MSI tumors. (BMC Cancer)
-
SCREENING
Combining FIT with risk factors improves colonoscopy efficiencyA systematic review of 19 studies found that adding risk factors such as age, sex, smoking, and fecal hemoglobin levels to fecal immunochemical testing modestly improved the yield and efficiency of colonoscopy for advanced colorectal neoplasia, though a small proportion of cases were missed. (BMC Gastroenterology)
-
RESEARCH
Circulating tumor DNA detects recurrence months before imagingA review of 94 publications found that postoperative ctDNA positivity was consistently associated with increased recurrence risk and poorer survival, with serial monitoring identifying molecular recurrence approximately 2.5 to 11.5 months before conventional surveillance. (Current Oncology)
This week's research spans survival outcomes in early-onset disease, advances in minimal residual disease detection, and ongoing efforts to improve screening access and efficiency.
Get CRC research intelligence delivered weekly, free.
SubscribeCRC Digest
Not Medical Advice
The CRC Digest provides research summaries for informational and educational purposes only. This is not medical advice. Always consult your healthcare provider before making any decisions about your care.
Content is curated with AI assistance and reviewed by the editorial team.
Browse Past Issues · Read our full disclaimer · Manage subscription
Useful? Forward it to a colleague. Many of the topics named here have a live research dossier, trajectory and evidence, at Signal Bureau.
Got this from a colleague? Subscribe here. We only ever add readers who sign themselves up.
Evolution Accelerator, Inc. (dba Evolution Labs) · 3941 Park Dr., Suite 20341, El Dorado Hills, CA 95762
You are receiving this because you subscribed to CRC Digest (self-serve signup)
Unsubscribe: honored promptly, no login required. · Privacy policy · Manage or delete your data